Moraxella (Branhamella) catarrhalis: Clinical, microbiological and immunological features in lower respiratory tract infections

APMIS, Supplement

Volumn 107, Issue 88, 1999, Pages 5-36

  Christensen, Jens Jørgen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; MINOCYCLINE; OFLOXACIN; BACTERIUM ANTIBODY;

ANTIBIOTIC THERAPY; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; HUMAN; IMMUNE STATUS; INFECTION RISK; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; PRIORITY JOURNAL; REVIEW; STRAIN DIFFERENCE; BLOOD; DRUG EFFECT; GENETICS; IMMUNOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NEISSERIACEAE INFECTION; RESPIRATORY TRACT INFECTION;

ANTIBODIES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; NEISSERIACEAE INFECTIONS; RESPIRATORY TRACT INFECTIONS;

EID: 0032609780     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.1999.tb05670.x     Document Type: Review

References (249)

1. Ahmad, F., McLeod, D.T., Croughan, M.J., Calder, M.A. Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections. Antimicrob. Agents Chemother. 6:424-425, 1984.
2. Ahmad, F., Young, H., McLeod, D.T., Croughan, M.J. and Calder, M.A. Characterization of Branhamella catarrhalis and differentiation from Neisseria species in a diagnostic laboratory. J. Clin. Pathol. 40:1369-1373, 1987.
3. Ahmed, K., Rikitomi, N., Ichinose, A., and Matsumoto, K.Possible presence of a capsule in Branhamella catarrhalis. Immunol. 35:361-366, 1991.
4. Ahmed, K., Rikitomi, N., and Matsumoto, K. Electron microscopic observation of Branhamella catarrhalis. Microbiol. Immunol. 34:967-975, 1990.
5. Alvarez, S., Jones, M., Holtsclaw-Berk, S., Guarderas, J. and Berk, S.L. In vitro susceptibilities of and β-lactamase production of 53 clinical isolates of Branhamella catar rhalis. Antimicrob. Ag. Chemother. 27:646-647, 1985.
6. Andersen, J. Neisseria meningitidis: The carrier state. Epidemiological and immunological investigations. Ph.D. thesis. Copenhagen 1996.
7. Arkwright, J.A. On the occurrence of the Micrococcus catarrhalis in normal and catarrhal noses and its differentiation from other Gram-negative cocci. J. Hyg. 7:145-154, 1907.
8. Avrameas, S. and Ternynck, T. The natural autoantibodies system: Between hypotheses and facts. Mol. Immunol. 30:1133-1142, 1993.
9. Bang, O. and Krag, P. Gonoreaktionen hos medicinske patienter. Ugeskr. Læg. 104:406-412, 1942.
10. Barry, A.L., Pfaller, M.A., Fuchs, P.C., Packer, R.R. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob. Agents Chemother 38:2419-2425, 1994.
11. Bartos, L.C. and Murphy, T.F. Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis. J. Infect. Dis. 158:761765, 1988.
12. Basran, G.S., Joseph J., Abbas A.M.A., Hughes, C., Tillotson, G.S. Treatment of acute exacerbations of chronic obstructive airways disease - a comparison of amoxycillin and ciprofloxacin. J. Antimicrob. Chemother. 26 (suppl. F):19-24, 1990.
13. Baumann, P., Doudoroff, M. and Stanier, R.Y. Study of the Moraxella group. I. Genus Moraxella and the Neisseria catarrhalis group. J. Bacteriol. 95:58-73, 1968.
14. Bealieu, D., Scriver, S., Bergeron, M.G., Low, D.E., Parr, T.R., Patterson, J.E., Matlow, A. and Roy, P.H. Epidemiological typing of Moraxella catarrhalis by using DNA probes. J. Clin. Microbiol. 31:736-739, 1993.
15. Berg, R.A. and Bartley, D.L. Pneumonia associated with Branhamella catarrhalis in infants. J. Pediatr. Infect. Dis. 6:569-573, 1987.
16. Berger, U. Reduktion von nitrat und nitrit durch Neisseria. Z. Hyg. Infektionskr. 148:45-50, 1961a.
17. Berger, U. Polysaccharidbildung durch saprophytische Neisserien. Zentrlbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt. 1 Orig. 181:345-349, 1961b.
18. Berger, U. and Paepcke, E. Untersuchungen über die asaccharolytischen Neisserien des menschlichen nasopharynx. Z. Hyg. Infektionskr. 148:269-281, 1962.
19. Berner, R., Schumacher, R.F., Brandis, M., Forster, J. Colonization and infection with Moraxella catarrhalis in childhood. Eur. J. Clin. Microbiol. Infect. Dis. 15:506-509, 1996.
20. Bezjak, V., Shah, H.N., Barley, J. Profiles of amino-acid utilisation and production amongst strains of Branhamella catarrhalis. J. Med. Microbiol. 26:143-146, 1988.
21. Bhushan, R., Craigie, R., and Murphy, T.F. Molecular cloning and characterization of outer membrane protein E of Moraxella (Branhamella) catarrhalis. J. Bacteriol. 176:6636-6643, 1994.
22. Black, A.J. and Wilson, T.S. Immunoglobulin G (IgG) serological response to Branhamella catarrhalis in patients with acute bronchopulmonary infections. J. Clin. Pathol. 41:329333, 1988.
23. Blackwell, C., Young, H. and Bain, S.S.R. Isolation of Neisseria meningitidis and Neisseria catarrhalis from the genitourinary tract and anal canal. Br. J. Vener. Dis. 54:41-44, 1978.
24. Boyle, F.M., Georghiou, P.R., Tilse, M.H., McCormack, J.G. Branhamella(Moraxella) catarrhalis: Pathogenic significance in respiratory infections. Med. J. Aust. 154:592-596, 1991.
25. Brogden, R.N., Carmine, A., Heel, R.C., Morley, P.A., Speight, T.M., Avery, G.S. amoxycillin/clavulanic acid: A review of its antibacterial activity, pharmakokinetics and therapeutic use. Drugs 22:337-362, 1981.
26. Brorson, J.-E., Axelsson, A., and Holm, S.E. Studies on Branhamella catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scand. J. Infect. Dis. 8:151-155, 1976.
27. Brorson, J.-E., and Malmvall, B.-E. Branhamella catarrhalis and other bacteria in the nasopharynx of children with longstanding cough. Scand. J. Infect. Dis. 13:111, 1981.
28. Brorson, J.-E., Martinell, J. and Wilske, H. Branhamella catarrhalis: Antibiotic susceptibility and β-lactamase production. J. Antimicrob. Chemother. 7:208-209, 1981.
29. Brown, B.A., Wallace, R.J., Flanagan, C.W., Wilson, R.W., Luman, J.I., Redditt, S.D. Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis. Antimicrob. Agents Chemother. 33:1631-1633, 1989.
30. Burman, L.Å., Leinonen, M. and Trollfors, B. Use of serology to diagnose pneumonia caused by nonencapsulated Haemophilus influenzae and Moraxella catarrhalis. J. Infect. Dis. 170:220-222, 1994.
31. Buu Hoi-Dang Van, A., Brive-Le Bouguenec, C., Barthelemy, M. and Labia, R. Novel β-lactamase from Branhamella catarrhalis. Ann. Microb. (Paris) 129B:397-406, 1978.
32. Bøvre, K. Affinities between Moraxella spp. and a strain of Neisseria catarrhalis as expressed by transformation. Acta Pathol. Microbiol. Scand 58:528-529, 1963.
33. Bøvre, K. Studies on transformation in Moraxella and organisms assumed to be related to Moraxella.8. The relative position of some oxidase negative immotile diplobacilli (Achromobacter) in the transformation system. Acta Pathol. Microbiol. Scand. 69:109-122, 1967a.
34. Bøvre, K. Transformation and DNA base composition in taxonomy with special reference to recent studies in Moraxella and Neisseria. Acta Pathol. Microbiol. Scand. 69:123-144, 1967b.
35. Bøvre, K. Proposal to divide the genus Moraxella Lwoff 1939 emend. Henriksen and Bøvre 1968 into two subgenera, subgenus Moraxella (Lwoff 1939) Bøvre 1979 and subgenus Branhamella (Catlin 1970) Bøvre 1979. Int. J. Syst. Bact. 29:403-406, 1979.
36. Bøvre, K. Genus II. Moraxella Lwoff 1939, emend. Henriksen and Bøvre 1968, p. 296-303. In: Krieg, N.R. and Holt, J.G. (eds.), Bergey's manual of systematic bacteriology, vol. 1. The Williams & Wilkins Co., Baltimore, 1984.
37. Bøvre, K., Fiandt, M. and Szybalski, W. DNA base composition of Neisseria, Moraxella, and Acinetobacter, as determined by measurement of buoyant density in CsCl gradients. Can. J. Microbiol. 15:335-338, 1969.
38. Bøvre, K. and Henriksen, S.D. An approach to transformation studies in Moraxella. Acta Pathol. Microbiol. Scand. 56:223-228, 1962.
39. Campagnari, A.A., Shanks, K.L., and Dyer, D.W. Growth of Moraxella catarrhalis with human transferrin and lactoferrin: expression of ironrepressible proteins without siderophore production. Infect. Immun. 62:4909-4914, 1994.
40. Campagnari, A.A., Spinola, S.M., Lesse, A.J., Abu Kwaik, Y., Mandrell, R.E., and Apicella, M.A. Lipooligosaccharide epitopes shared among gram-negative nonenteric mucosal pathogens. Microb. Pathog. 8:353-362, 1990.
41. Catlin, B.W. Reciprocal transformation between Neisseria catarrhalis and Moraxella nonliquefaciens. J. Gen. Microbiol. 37:369-379, 1964.
42. Catlin, B.W. Transfer of the organism named Neisseria catarrhalis to Branhamella gen. nov. Int. J. Syst. Bact. 20:155-159, 1970.
43. Catlin, B.W. Neisseria meningitidis (meningococcus), p. 76-81. In: Blair, J.E., Lennette, E.H., and Truant, J.P. (eds.), Manual of clinical microbiology, American Society for Microbiology, Washington, D.C., 1974.
44. Catlin, B.W. Cellular elongation under the influence of antibacterial agents; way to differentiate coccobacilli from cocci. J. Clin. Microbiol. 1:102-105, 1975.
45. Catlin, B.W. Branhamella catarrhalis: An organism gaining respect as a pathogen. Clin. Microbiol. Rev. 3:293320, 1990.
46. Catlin, B.W. Branhamaceae fam. nov., a proposed family to accomodate the genera Branhamella and Moraxella. Int. J. Syst. Bact. 41:320-323, 1991.
47. Catlin, B.W. and Cunningham, L.S. Transforming activities and base contents of deoxyribonucleate preparations from various neisseriae. J. Gen. Microbiol. 26:303-312, 1961.
48. Catlin, B.W. and Cunningham, L.S. Genetic transformation of Neisseria catarrhalis by deoxynucleate preparations having different average base compositions. J. Gen. Microbiol. 37:341-352, 1964a.
49. Catlin, B.W. and Cunningham, L.S. Transforming activities and base composition of deoxyribonucleates from strains of Moraxella and Mima. J. Gen. Microbiol. 37:353-367, 1964b.
50. Chapman Jr., A.J., Musher, D.M., Jonsson, S., Clarridge, J.E. and Wallace Jr, R. J., Development of bactericidal antibody during Branhamella catarrhalis infection. J. Infect. Dis. 151:878882, 1985.
51. Chi, D.S., Verghese, A., Moore, C., Hamati, F. and Berk, S. Antibody response to Pprotein in patients with Branhamella catarrhalis infections. Americ. J. Med. 88(suppl. 5A):2527, 1990.
52. Chodosh, S. Bronchitis and asthma. In: Gorbach, S.L., Bartlett, J.G., Blacklow, N.R. (eds.) Infectious Diseases. Philadelphia, Saunders, 1992.
53. Christensen, J.J. and Bruun, B. Bacteremia caused by a beta-lactamase producing strain of Branhamella catarrhalis. Acta path. microbiol. immunol. scand. Sect. B, 93:273-275, 1985.
54. Christensen, J.J., Keiding, J., Schumacher, H. and Bruun, B. Recognition of a new Branhamellacatarrhalis β-lactamase - BRO-3. J. Antimicrob. Chemother. 28:774-775, 1991.
55. Chun, P.K., Sensabaugh, G.F. and Vedros, N.A. Genetic relationships among Neisseria species assessed by comparative enzyme electrophoresis. J. Gen. Microbiol. 131:3105-3115, 1985.
56. Coffey, Jr., J.D., Martin, A.D., Booth, H.N. Neisseria catarrhalis in exudate otitis media. Arch. Otolaryngol. 86:403-406, 1967.
57. Collatz, E., Labia, R. and Gutmann, G. Molecular evolution of ubiquitous β-lactamases towards extended-spectrum enzymes active against newer β-lactam antibiotics. Molecular Microbiol. 4:1615-1620, 1990.
58. Cook, P.P., Hetch, D.W. and Snydman, D.R. Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: Risk factors for disease. J. Hosp. Infect. 13:299-307, 1989.
59. Cooper, C.E., Slocombe, B., White, A.R. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against β-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae. J. Antimicrob. Chemother. 26:371-380, 1990.
60. Corkill, J.E. and Makin, T. A selective medium for non-pathogenic aerobic Gram negative cocci from the respiratory tract, with special reference to Branhamella catarrhalis. Med. Lab. Sci. 39:3-10, 1982.
61. Cowan, S.T. Cowan and Steel's manual for the identification of medical bacteria, 2nd ed., p. 80-83, University Press, Cambridge, 1974.
62. Cox, P.M. Jr. and Colloff, E. Neisseria catarrhalis empyema in an immunodeficient host. Am. Rev. Respir. Dis. 120:471-472, 1979.
63. D'Amato, R.F., Eriquez, L.A., Tomfohrde, K.M., Singerman, E. Rapid identification of Neisseria gonorrhoeae and Neisseria meningitidis by using enzymatic profiles. J. Clin. Microbiol. 7:77-81, 1978.
64. Davies, B.I. and Maesen, F.P.V. Respiratory infections: Clinical experiences with the new quinolones. Pharmaceutisch Weekblad (Scientific Edition) 9: Suppl., S53-57, 1987.
65. Davies, B.I., Maesen, F.P.V. The epidemiology of respiratory tract pathogens in Southern Netherlands. Eur. Respir. J. 1:415-420, 1988.
66. Davies, B.I. and Maesen, F.P.V. Treatment of Branhamella catarrhalis infections (Leading article). J. Antimicrob. Chemother. 25:1-7, 1990.
67. Davies, B.I., Maesen, F.P.V. and Baur, C. Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis. Eur. J. Clin. Microbiol. 5:226-231, 1986.
68. Davies, B.I., Maesen, F.P.V., and Gubbelmans, R. Azitromycin (CP-62,993) in acute exacerbations of chronic bronchitis: An open clinical, microbiological and pharmacokinetic study. J Antimicrob. Chemother. 23:743-751, 1989.
69. Dealler, S.F., Abbott, M., Croughan, M.J. and Hawkey, P.M. Identification of Branhamella catarrhalis in 2.5 min with an indoxyl butyrate strip test. J. Clin. Microbiol. 27:1390-1391, 1989.
70. Denamur E., Picard-Pasquier, N., Mura, C., Picard, B., Orfila, J. and Krishnamoorthy, R. Comparison of molecular epidemiological tools for Branhamella catarrhalis typing. Res. Microbiol. 142:585-589, 1991.
71. Dickinson D.P., Loos, B.G., Dryja, D.M., Bernstein, J.M. Restriction fragment mapping of Branhamella catarrhalis: A new tool for studying the epidemiology of this middle ear pathogen. J. Infect. Dis. 158:205-208, 1988.
72. Dillon, J.R., Carballo, M., and Pauze'. Evaluation of eight methods for identification of pathogenic Neisseria species: Neisseria-Kwik, RIM-N, Gonobio-Test, Minitek, Gonocheck II, GonoGen, Phadebact Monoclonal GC OMNI Test, and Syva MicroTrak Test. J. Clin. Microbiol. 26:493-497, 1988.
73. Doern, G.V. Branhamella catarrhalis - An emerging human pathogen. Diagn. Microbiol. Infect. Dis. 4:191-201, 1986.
74. Doern, G.V., Brueggemann, A.B., Pierce, G., Hogan, T., Holley, Jr., H.P. and Rauch, A. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: Results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:2884-2886, 1996.
75. Doern, G.V. and Jones, R.N. Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catar rhalis, and Neisseria gonorrhoeae. Antimicrob. Ag. Chemother. 32:1747-1753, 1988.
76. Doern, G.V. and Morse, S.A. Branhamella (Neisseria) catarrhalis: criteria for laboratory identification. J. Clin. Microbiol. 11:193-195, 1980.
77. Doern, G.V., Siebers, K.G., Hallick, L.M. and Morse, S.A. Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis. Antimicrob. Ag. Chemother. 17:24-29, 1980.
78. Doern; G.V. and Tubert, T.A. Disk diffusion susceptibility testing of Branhamella catarrhalis with ampicillin and seven other antimicrobial agents. Antimicrob. Agents Chemother. 31:1519-1523, 1987a.
79. Doern, G.V. and Tubert, T.A. Detection of β-lactamase activity among clinical isolates of Branhamella catarrhalis with six different β-lactamase assays. J. Clin. Microbiol. 25:1380-1383, 1987b.
80. Doern, G.V. and Tubert, T.A. In vitro activities of 39 anti microbial agents for Branhamella catarrhalis and comparison of results with different quantitative susceptibility test methods. Antimicrob. Agents Chemother. 32:259-261, 1988.
81. Dunn, R.A. and Gordon, M.H. Clinical and bacteriological aspects of an epidemic simulating influenza. Br. Med. J. ii:421-427, 1905.
82. Durussel, C., and Siegrist, H.H. Evaluation of three commercial systems for the identification of pathogenic Neisseria and Branhamella species against the conventional method. Zentralbl. Bakteriol. Mikrobiol. Hyg. Reihe A 268:318-324, 1988.
83. Edebrink, P., Jansson, P.-E., Rahman, M.M., Widmalm, G., Holme, T., Rahman, M., and Weintraub, A. Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr. Res. 257:269-284, 1994.
84. Editorial. Branhamella catarrhalis: Pathogen or opportunist. Lancet i:1056, 1982.
85. Ejlertsen, T. Branhamella catarrhalis: Prevalence and immunologic response in children. Antimicrobial resistance among isolates from children. Ph.D. thesis. Århus 1995.
86. Ejlertsen, T., Schønheyder, H. Branhamella catarrhalis as a cause of multiple subpleural abscesses. Scand. J. Infect. Dis. 23:117-118, 1991.
87. Ejlertsen, T. and Skov, R. The β-lactamases of Moraxella (Branhamaella) catarrhalis isolated from danish children. APMIS 104:557-562, 1996.
88. Ejlertsen, T., Thisted, E., Ebbesen, B., Olesen, B. and Renneberg, J. Branhamella catarrhalis in children and adults. A study of prevalence, time of colonisation, and association with upper and lower respiratory tract infections. J. Infect. 29:23-31, 1994.
89. Ejlertsen, T., Thisted, E., Østergaard, P.Å., Renneberg, J. Maternel antibodies and acquired serological response to Moraxella catarrhalis in children determined by an enzyme-linked immunosorbent assay. Clin. Diag. Lab. Immunol. 1:464-468, 1994.
90. Eliasson, I. A protein antigen characteristic of Branhamella catarrhalis. Serological identification of the genus. Acta path. microbiol. scand. Sect. B. 88:281-286, 1980.
91. Eliasson, I. β-lactamases in respiratory tract bacteria. Characterization of β-lactamases in Branhamella catarrhalis. Thesis. Studentlitteratur, Lund, Sweden, 1990.
92. Eliasson, I., Kamme, C., Characterization of the plasmidmediated β-lactamase in Branhamella catarrhalis, with special reference to substrate affinity. J. Antimicrob. Chemother. 15:139-149, 1985.
93. Eliasson, I., Kamme, C. and Prellner, K. Beta-lactamase production in the upper respiratory tract flora. Eur. J. Clin. Microbiol. 5:507-512, 1986.
94. Elser, W.J. & Huntoon, F.M. Studies on meningitis. J. Med. Res. 20:373-541, 1909.
95. Faden, H., Hong, J., and Murphy, T.F. Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media. Infect. Immun. 60:3824-3829, 1992.
96. Faden, H., Harabuchi, Y., Hong, J.J., and Tonawanda/Williamsville pediatrics. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: Relationship to otitis media. J. Infect. Dis. 169:1312-1317, 1994.
97. Faou, A.L. and Rio, A. Branhamella catarrhalis en pathologie infectieuse des voies aerienne. La Presse Med. 12:2035-2037, 1983.
98. Farholt, S. and Lind, I. Conjunctivitis neonatorum. Fund af Neisseria species og Branhamella catarrhalis i årene 1986-91. Nyt om Mikrobiologi (Danish domestic newsletter). No 31:1-4, 1992.
99. Farmer, T. and Reading, C. Beta-lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid. Antimicrob. Ag. Chemother. 21:506-508, 1982.
100. Fernandez-Roblas, R., Jimenez Arriero, M., Rodriguez-Tudela, J.L. and Soriano, F. In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis. J Antimicrob. Chemother. 22:867-872, 1988.
101. Fomsgaard, J.S., Fomsgaard, A., Høiby, N., Bruun, B., and Galanos, C. Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains. Infect. Immun. 59:3346-3349, 1991.
102. Fox, R.H. and McClain, D.E. Evaluation of the taxonomic relationship of Micrococcus cryophilus, Branhamella catar rhalis, and neisseriae by comparative polyacrylamide gel electrophoresis of soluble proteins. Int. J. Syst. Bact. 24:172-176, 1974.
103. Frosch, P. and Kolle, W. Die Mikrokokken, p. 154-155. In C. Flùgge (ed.), Die Mikrorganismen, vol. 2. Verlag von Vogel, Leipzig, 1896.
104. Gerding, D.N., Hughies, C.E., Bamberger, D.M., Foxworth, J., Larson, T.A. Extravascular antimicrobial distribution and the respective blood concentrations in humans, p. 851. In: Lorian, V. (ed.), Antibiotics in laboratory medicine, Williams & Wilkins, 1996.
105. Goldblatt, D., Turner, M.W. and Levinsky, R.J. Branhamella catarrhalis: Antigenic determinants and the development of the IgG subclass response in childhood. J. Infect. Dis. 162:11281135, 1990.
106. Goodfellow, M., and O'Donnell, A.G. In: Goodfellow, M., and O'Donnell (eds.): Handbook of new bacterial systematics. p. 4. Academic Press, Harcourt Brace & Company, Publishers, 1993.
107. Gordon, J.E. The Gram-negative cocci in "colds" and influenza. J. Infect. Dis. 29:462-494, 1921.
108. Gudbrandsson, F.K. Mellanöroninflammationer och vätskeansamling i mellanörat hos isländska barn. Nord. Med. 107:83-84, 1992.
109. Guibourdenche, M., Popoff, M.Y., and Riou, J.Y. Deoxyribonucleic acid relatedness among Neisseria gonorrhoeae, N. meningitidis, N. lactamica, N. cinerea, and "Neisseria polysaccharea". Ann. Inst. Pasteur/Microbiol. (Paris) 137B:177-185, 1986.
110. Haddad, J., Le Faou, A., Simeoni, U., and Messer, J. Hospital-acquired bronchopulmonary infection in premature infants due to Branhamella catarrhalis. J. Hosp. Infect. 7:301-302, 1986.
111. Hager, H., Verghese, A., Alvarez, S. and Berk, S.L. Branhamella catarrhalis respiratory infections. Rev. Infect. Dis. 9:11401149, 1987.
112. Helminen, M.E., Beach, R., Maciver, I., Jarosik, G., Hansen, E.J. and Leinonen, M. Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay. Clin. Diagn. Lab. Immunol. 2:35-39, 1995.
113. Helminen, M.E., Maciver, I., Latimer, J.L., Cope, L.D., McCracken Jr., G.H. and Hansen E.J. A major outer membrane protein of Moraxella catarrhalis is a target for anti bodies that enhance pulmonary clearance of the pathogen in an animal model. Infect. Immun. 61:2003-2010, 1993a.
114. Helminen, M.E., Maciver, I., Latimer, J.L., Klesney-Tait, J., Cope, L.D., Paris, M., McCracken Jr., G.H. and Hansen, E.J. A large antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J. Infect. Dis. 170:867-872, 1994.
115. Helminen, M.E., Maciver, I., Paris, M., Latimer, J.L., Lumbley, S.L., Cope, L.D., McCracken Jr., G.H., and Hansen, E.J. A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo. J. Infect. Dis. 168:1194-1201, 1993b.
116. Hoff, G.E. and Høiby, N. Cross-reactions between Neisseria meningitidis and twenty-seven other bacterial species. Acta path. microbiol. scand. Sect. B, 86:87-92, 1978.
117. Hoke, C., and Vedros, N.A. Taxonomy of the Neisseriae: deoxyribonucleic acid base composition, interspecific transformation, and deoxyribonucleic acid hybridization. Int. J. Syst. Bacteriol. 32:57-66, 1982.
118. Hsiao, C.B., Sethi, S. and Murphy, T.F. Outer membrane protein CD of Branhamella catarrhalis: Sequence conservation in strains recovered from the human respiratory tract. Microb. Pathogen. 19:215-225, 1995.
119. Huebner, J., Berner, R., Schumacher, R.F., Kropec, A., Brandis, M., Forster, J. Epidemiology and clinical significance of Moraxella catarrhalis in upper respiratory tract infections in children. Med. Microbiol. Lett. 5:195-203, 1996.
120. Højbjerg, T and Fogh, A. Branhamella catarrhalis and acute otitis media. Symposium on Branhamella catarrhalis in respiratory tract infections. Astra Alab Ab, Södertälje, Sverige, p. 31-32, 1987.
121. Ikram, R.B., Nixon, M., Aitken, J., and Wells, E. A prospective study of isolation of Moraxella catarrhalis in a hospital during the winter months. J. Hosp. Infect. 25:7-14, 1993.
122. Ioannidis, J.P.A., Worthington, M., Griffiths, J.K. and Snydman, D.R. Spectrum and significance of bacteremia due to Moraxella catarrhalis. Clin. Infect. Dis. 21:390-397, 1995.
123. Janda, J.M. and Ruther, P.B. CAT CONFIRM, a rapid test for confirmation of Branhamella catarrhalis. J. Clin. Microbiol. 27:1130-1131, 1989.
124. Janda, W.M., Ulanday, M.G., Bohnhoff, M., and LeBeau, L.J. Evaluation of the RIM-N, Gonochek II, and Phadebact systems for the identification of pathogenic Neisseria spp. and Branhamella catarrhalis. J. Clin. Microbiol. 21:734-737, 1985.
125. Janda, W.M., Zigler, K.L., and Bradna, J.J. API Quad-FERM+ with rapid Dnase for identification of Neisseria spp. and Branhamella catarrhalis. J. Clin. Microbiol. 25:203-206, 1987.
126. Jannes, G., Vaneechoutte, M., Lannoo, M., Gillis, M., Vancanneyt, M., Vandamme, P., Verschraegen, G., van Heuverswyn; H. & Rossau, R. Polyphasic taxonomy leading to the proposal of Moraxella canis sp. nov. for Moraxella catarrhalis-like strains. Int. J. Syst. Bact. 43:438-449, 1993.
127. Johnson, M.A., Drew, W.L. and Roberts, M. Branhamella (Neisseria) catarrhalis - a lower respiratory tract pathogen? J. Clin. Microbiol. 13:1066-1069, 1981.
128. Jones, R.N. and Sommers, H.M. Identification and antimicrobial susceptibility testing of Branhamella catarrhalis in United States Laboratories, 1983-1985. Drugs 31 (Suppl. 3):34-37, 1986.
129. Jorgensen, J.H., Doern, G.V., Maher, L.A., Howell, A.W., Redding, J.S. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob. Agents Chemother. 34:2075-2080, 1990.
130. Juni, E., Heym, G.A., and Avery, M. Defined medium for Moraxella (Branhamella) catarrhalis. Appl. Environ. Microbiol. 52:546-551, 1986.
131. Jönsson, I., Eriksson, B. and Krook, A. Minimal criteria for identification of Moraxella (Branhamella) catarrhalis. APMIS 98:954-956, 1990.
132. Jönsson, I., Holme, T., and Krook, A. Significance of isolation of Moraxella catarrhalis in routine cultures from the respiratory tract in adults: Antibody response studied in a whole cell EIA. Scand. J. Infect. Dis. 26:553-558, 1994.
133. Jönsson, I., Holme, T., Krook, A., Rahman, M., Thoren, M. Variability of surface-exposed antigens of different strains of Moraxella catarrhalis. Eur. J. Clin. Microbiol. Infect. Dis. 11:919-922, 1992.
134. Kallings, I., Bengtsson, S., Christensen, P., Holm, S.E., Lind, L., Kalin, M. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden. Scand. J. Infect. Dis. (Suppl.)39:100-105, 1983.
135. Kamme, C., Eliasson, I., Knutson, B.K. and Vang, M. Plasmid-mediated β-lactamase in Branhamella catarrhalis. Drugs 31 (Suppl. 3):55-63, 1986.
136. Kamme, C., Lundgren, K., and Mårdh, P.-A. The aetiology of acute otitis media in children. Scand. J. Infect. Dis. 3:217-223, 1971.
137. Kamme, C., Vang, M., Stahl, S. Intrageneric and intergeneric transfer of Branhamella catarrhalis β-lactamase production. Scand. J. Infect. Dis. 16:153-155, 1984.
138. Karjalainen, H., Koskela, M., Luotonen, J., Herva, E., and Sipilä, P. Antibodies against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis in middle ear effusion during early phase of acute otitis media. Acta Otolaryngol. 109:111-118, 1990.
139. Kawakami, Y., Ueno, I., Katsuyama, T., Furihata, K., and Matsumoto, H. Restriction fragment lenght polymorphism (RFLP) of genomic DNA of Moraxella (Branhamella) catarrhalis isolates in a hospital. Microbiol. Immunol. 38:891-895, 1994.
140. Keren, G., Bogokowsky, B. and Barzilay, Z. Branhamella catarrhalis pneumonia in non-immunocompromised pediatric patients: Report of three cases and review of the literature. J. Med. 20:65-71, 1989.
141. Kerttula, Y., Leinonen, M., Koskela, M. and Mäkela, P.H. The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods. J. Infect. 14:21-30, 1987.
142. Kingsbury, D.T. Deoxyribonucleic acid homologies among species of the genus Neisseria. J. Bacteriol. 94:870-874, 1967.
143. Kingsbury, D.T., Fanning, G.R., Johnson, K.E., and Brenner, D.J. Thermal stability of interspecies Neisseria DNA duplexes. J. Gen. Microbiol. 55:201-208, 1969.
144. Klingman, K.L., and Murphy, T.F. Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis. Infect. Immun. 62:1150-1155, 1994.
145. Knapp, J.S. Historical perspectives and identification of Neisseria and related species. Clin. Microbiol. Rev. 1:415-431, 1988.
146. Knapp, J.S. and Holmes, K.K. Modified oxidation-fermentation medium for detection of acid production from carbohydrates by Neisseria spp. and Branhamella catarrhalis. J. Clin. Microbiol. 18:56-62, 1983.
147. Knapp, J.S., Totten, P.A., Mulks, M.H. and Minshew, B.H. Characterization of Neisseria cinerea, a non pathogenic species isolated on Martin-Lewis medium selective for pathogenic Neisseria spp. J. Clin. Microbiol. 19:63-67, 1984.
148. Kodjo, A.T., Richard, Y., and Tønjum, T. Moraxella boevrei sp. nov., a new species found in goats. Int. J. Syst. Bact. 47:115-121, 1997.
149. Kodjo, A.T., Tønjum, T., Richard, Y., and Bøvre, K. Moraxella caprae sp. nov., a new member of the classical moraxellae. Int. J. Syst. Bact. 45:467-471, 1995.
150. Kostiala, A.A.I. and Honkanen, T. Branhamella catarrhalis as a cause of acute purulent pericarditis. J. Infect. 19:291-292, 1989.
151. Kristensen, M. Die Komplementbindundungsreaktion bei gonorrhöe (Technik). Acta path. microbiol. scand. 7:87-106, 1930.
152. Lambert, H.P. and O'Grady, F.W. Antibiotic and chemotherapy. Sixth edition. Churchill Livingstone, 1992.
153. Lange, P.K., Reyn, A., Bentzon, M.W. og Lind, I. Gonoreaktion hos grønlandske patienter med lungelidelse. Ugeskr. Læger. 128:409-415, 1966.
154. Lairscey, R.C. and Kelly, M.T. Evaluation of a one-hour test for identification of Neisseria species. J. Clin. Microbiol. 22:238-240, 1985.
155. Leinonen, M., Luotonen, J., Herva, E., Valkonen, K., Mäkela, P.H. Preliminary serological evidence for a pathogenic role of Branhamella catarrhalis. J. Infect. Dis. 144:570-574, 1981.
156. Lindsay, G., Scorer, H.J.N., Carnegie, C.M.D. Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: a randomised, double-blind trial. J. Antimicrobial. Chemother. 30:89-100, 1992.
157. Luman, I., Wilson, R.W., Wallace, Jr., R.J., and Nash, D.R. Disk diffusion susceptibility of Branhamella catarrhalis and relation to β-lactam zone size to β-lactamase production. Antimicrob. Agents Chemother. 30:774-776, 1986.
158. Lwoff, A. Revision et demembrement des Hemophileae, le genre Moraxella nov. gen. Ann. Inst. Pasteur (Paris). 62:168-176, 1939.
159. Malmvall, B.-E., Brorsson, J.-E. and Johnsson, J. In vitro sensitivity to penicillin V and beta-lactamase production of Branhamella catarrhalis. J. Antimicrob. Chemother. 3:374-375, 1977.
160. Mannheim, W. and Bürger, H. The taxonomic significance of some bacterial hydrolase reactions - preliminary results, p. 199-202. In: Reports from the conference on the taxonomy of bacteria held in the Czechoslovak Collection of Microorganisms, September 1967, Brno, Spisy, University J. E. Purkyne Publications, Brno, Czechoslovakia, 1967.
161. Mannion, P.T. Sputum microbiology in a district general hospital: the role of Branhamella catarrhalis. Br. J. Dis. chest. 81:391-396, 1987.
162. Mannion, P.T. Tributyrin hydrolysis for identifying Branhamella catarrhalis. J. Clin. Pathol. 42:115, 1989.
163. Marmur, J. and Doty, P. Determination of the base composition of deoxyribonucleic acid from its thermal denaturation temperature. J. Mol. Biol. 5:109-118, 1962.
164. Marriott, D. and Dorman, D.C. Branhamella catarrhalis: A respiratory pathogen in children. Aust. NZ J. Med. 16:247, 1986.
165. Masaoud, H., Perry, M.B., and Richards, J.C. Characterization of the lipopolysaccharide of Moraxella catarrhalis. Structural analysis of the lipid A from M. catarrhalis serotype A lipopolysaccharide. Eur. J. Biochem. 220:209-216, 1994.
166. McKenzie, H., Morgan, M.G., Jordens, J.Z., Enright, M.C., and Bain, M. Characterization of hospital isolates of Moraxella (Branhamella) catarrhalis by SDS-PAGE of whole-cell proteins, immunoblotting and restriction-endonuclease analysis. J. Med. Microbiol. 37:70-76, 1992.
167. McLeod, D.T., Ahmad, F., Croughan, M.J. and Calder, M.A. Bronchopulmonary infection due to Branhamella catarrhalis. Clinical features and therapeutic response. Drugs (Suppl. 3) 31:109112, 1986.
168. McLeod, D.T., Ahmad, F., Power, J.T., Calder, M.A. and Seaton, A. Bronchopulmonary infection due to Branhamella catarrhalis. Br. Med J. 287:1446-1447, 1983.
169. McNeely, D.J., Kitchens, C.S., Kluge, R.M. Fatal Neisseria (Branhamella) catarrhalis pneumonia in an immunodeficient host. Am. Rev. Resp. Dis. 114:399-402, 1976.
170. Melchior, N.H. and Keiding, J. In-vitro evaluation of ampicillin/brobactam and comparison with other β-lactam antibiotics. J. Antimicrob. Chemother. 27:29-40, 1991.
171. Morello, J.A., Janda, W.M. and Bohnhoff, M. Neisseria and Branhamella, p. 176-192. In: Lennette, E.H., Balows, A., Hausler, Jr., W.J. and Shadomy, H.J. (eds.). Manual of clinical microbiology, 4th ed., American Society for Microbiology, Washington, D.C., 1985.
172. Morgan M.G., McKenzie, H., Enright, M.C., Bain, M., Emmanuel, F.X.S. Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection. Eur. J. Clin. Microbiol. Infect. Dis. 11:305-312, 1992.
173. Murphy, T.F. Branhamella catarrhalis: Epidemiology, surface antigenic structure, and immune response. Microbiol. Rev. 60:267-279, 1996.
174. Murphy, T.F. and Bartos, L.C. Surfaceexposed conserved determinants of outer membrane proteins of Branhamella catarrhalis. Infect. Immun. 57:29382941, 1989.
175. Murphy, T.F. and Loeb, M.R. Isolation of the outer membrane of Branhamella catarrhalis. Microbial. Pathogen. 6:159174, 1989.
176. Murphy, T.F., Kirkham, C. and Lesse, J. The major heat-modifiable outer membrane protein CD is highly conserved among strains of Branhamella catarrhalis. Mol. Microbiol. 10::87-97, 1993.
177. Murphy, T.F., Sethi, S. Bacterial infection in chronic obstructive pulmonary disease. Am. Rev. Resp. Dis. 146:1067-1083, 1992.
178. Nagatake, T. Clinical significance of respiratory infection caused by Branhamella catarrhalis with special reference to (lactamase producing strains. Tohoku J. Exp. Med. 147:113, 1985.
179. Nash, D.R., Wallace Jr., R.J., Steingrube, V.A., Shurin, P.A. Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella
180. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Fourth Information Supplement. NCCLS Document M100-S4 (ISBN 1-56238-172-5). NCCLS, 771 E. Lancaster Avenue, Villanova, Pennsylvania: 19085, 1992.
181. Nicotra, B., Rivera, M., Luman, J.I. and Wallace, R.J. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch. Intern. Med. 146:890-893, 1986.
182. Ninane, G., Joly, J. & Kraytman, M. Bronchopulmonary infection due to Branahamella catarrhalis: 11 cases assessed by transtracheal puncture. Br. Med. J. 1:276-278, 1978.
183. Norrod, E.P., Bartenstein, L. and Morse, S.A. Comparison of the superoxide dismutases of Branhamella catarrhalis, Neisseria ovis, and Neisseria caviae. Int. J. Syst. Bact. 31:392-395, 1981.
184. O'Callaghan, C.H., Morris, A., Kirby, S.M. and Shingler, A.H. Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrob. Ag. Chemother. 1:283-288, 1972.
185. Ohlsson, A. and Bailey, T. Neonatal pneumonia caused by Branhamella catarrhalis. Scand J. Infect. Dis. 17:225-228, 1985.
186. Patterson T.F., Patterson, J.E., Masecar, B.L., Barden, G.E., Hierholzer, W.J. and Zervos, M.J. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. J. Infect. Dis. 157:996-1001, 1988.
187. Patterson J.E., Patterson, T.F., Farrel, P., Hierholzer JR, W.J. and Zervos, M.J. Evaluation of restriction endonuclease analysis as an epidemiologic typing system for Branhamella catarrhalis. J. Clin. Microbiol. 27:944-946, 1989.
188. Peiris, V. and Heald, J. Rapid method for differentiating strains of Branhamella catarrhalis. J. Clin. Pathol. 45:532-533, 1992.
189. Percival, A., Corkill, J.E., Rowlands, J. and Sykes, R.B. Pathogenecity of and β-lactamase production by Branhamella (Neisseria) catarrhalis. Lancet 1175, 1977.
190. Philippon, A., Riou, J.Y., Guibourdenche, M., and Sotolongo, F. Detection, distribution and inhibition of Branhamella catarrhalis β-lactamases. Drugs 31 (Suppl.):64-69, 1986.
191. Picard, B., Goullet, P., Denamur, E. and Suermondt, G. Esterase electrophoresis: A molecular tool for studying the epidemiology of Branhamella catarrhalis nosocomial infection. Epidem. Inf. 103:547-554, 1989.
192. Pollard, J.A., Wallace, R.J., Nash, D.R., Luman, J.I. and Wilson, R.W. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease. Drugs 31 (Suppl. 3):103-108, 1986.
193. Rahman, M., Holme, T., Jönsson, I., Krook, A. Lack of serotype-specific antibody response to lipopolysaccharide antigens of Moraxella catarrhalis during lower respiratory tract infection. Eur. J. Clin. Microbiol. Infect. Dis. 14:297-304, 1995.
194. Rahman, M., Holme, T., Jönsson, I. and Krook, A. Human immunoglobulin isotype and IgG subclass response to different antigens of Moraxella catarrhalis. APMIS 105:213-220, 1997.
195. Reyn, A. Demonstration of antigenic relationship between Micrococcus catarrhalis and gonococci. Acta path. microbiol. scand. 20:257-271, 1943.
196. Reyn, A. Family I. Neisseriaceae Prevot 1933, p.427-433, 442-443. In: Buchanan, R.E. and Gibbon, N.E. (eds.). Bergey's manual of determinative bacteriology, 8th ed. The Williams & Wilkins Co, Baltimore, 1974.
197. Richards, J. Evaluation of a rapid method for identifying Branhamella catarrhalis. J. Clin. Pathol. 41:462-464, 1988.
198. Richards, S.J., Greening, A.P., Enright, M.C., Morgan, M.G., and McKenzie, H. Outbreak of Moraxella catarrhalis in a respiratory unit. Thorax 48:91-92, 1993.
199. Rikitomi, N., Andersson, B., Matsumoto, K., Lindstedt, R., and Svanborg, C. Mechanism of adherence of Moraxella (Branhamella) catarrhalis. Scand. J. Infect. Dis. 23:559-567, 1991.
200. Riley, T.V. A note on hydrolysis of tributyrin by Branhamella and Neisseria. J. Appl. Bacteriol. 62:539-542, 1987.
201. Riley, T.V., Digiovanni, C., Hoyne, G.F. Susceptibility of Branhamella catarrhalis to sulphamethoxazole and trimetoprim. J. Antimicrob. Chemother. 19:39-43, 1987.
202. Riou, J.Y., Buissiere, J., Guibourdenche, M., Brault, G. and Carlier, J.P. Hydrolyse de la tributyrine par les Neisseria et les Branhamella. Ann. Microbiol. (Paris) 132A:159-169, 1981.
203. Riou, J.Y., Buissiere, J., Richard, C. and Guibourdenche, M. Interet de la recherche de la γ-glutamyl-transferase chez les Neisseriaceae. Ann. Microbiol. (Paris) 133A:387-392, 1982.
204. Riou, J.Y. and Guibourdenche, M. Diagnostic bacteriologique des especes des genres Neisseria et Branhamella. Ann. Biol. Clin. 35:73-87, 1977.
205. Riou, J.Y. and Guibourdenche, M. Branhamella catarrhalis: new methods of bacterial diagnosis. Drugs (Suppl.) 31:1-6, 1986.
206. Roberts, M.C., Brown, B.A., Steingrube, V.A. and Wallace, JR, R.J. Genetic basis of tetracycline resistance in Moraxella (Branhamella) catarrhalis. Antimicrob. Agents Chemother. 34:1816-1818, 1990.
207. Roberts, M.C., Pang, Y., Spencer, R.C., Winstanley, T.G., Brown, B.A., and Wallace, Jr., R.J. Tetracycline resistance in Moraxella (Branhamella) catarrhalis: Demonstration of two clonal outbreaks by using pulsed-field gel electrophoresis. Antimicrob. Agents Chemother. 35:2453-2455, 1991.
208. Robinson, A., Johnson, P.C., Griffith, S.B. Clinical interpretation of beta-lactamase-producing strains of Branhamella catarrhalis in sputum Gram's stain and culture. Am. J. Clin. Pathol. 87:498-503, 1987.
209. Rossau, R., Kersters, K., Falsen, E., Jantzen, E., Segers, P., Union, A., Nehls, L. and De Ley, J. Oligella, a new genus including Oligella urethralis comb. nov. (formerly Moraxella urethralis) and Oligella ureolytica sp. nov. (formerly CDC group Ive): Relationship to Taylorella equigenitalis and related taxa. Int. J. Syst. Bacteriol. 37:198-210, 1987.
210. Rossau, R., Van Landschoot, A., Gillis, M. and De Ley, J. Taxonomy of Moraxellaceae fam. nov., a new bacterial family to accomodate the genera Moraxella, Acinetobacter, and Psychrobacter and related organisms. Int. J. Syst. Bact. 41:310-319, 1991.
211. Rossau, R., Van Landschoot, A., Mannheim, W. and De Ley, J. Inter-and intrageneric similarities of ribosomal ribonucleic acid cistrons of the Neisseriaceae. Int. J. Syst. Bacteriol. 36:323-332, 1986.
212. Sarwar, J., Campagnari, A.A., Kirkham, C. and Murphy T.F. Characterization of an antigenically conserved heatmodifiable major outer membrane protein of Branhamella catarrhalis. Infect. Immun. 60:804-809, 1992.
213. Schalen, L., Andersson, K., Becker, K., Bergendal, B., Christensen, P., Fex, S., Kamme, C., Klingvall, B., Pettersson, K.-I., and Schalen, C. Acute laryngitis in adults. Etiological and phoniatric aspects. Acta Otolaryngol. Suppl. 386:203-205, 1982.
214. Schildkraut, C.L., Marmur, J., and Doty, P. Determination of the base composition of deoxyribonucleic acid from its buoyant density in CsCl. j. Mol. Biol. 4:430, 1962.
215. Schumacher, H., Nir, M., Mansa, B. and Thomsen, V.F. Screening method for substrate profiles. APMIS 100:479-489, 1992.
216. Schønheyder, H. and Ejlertsen, T. Branhamella catarrhalis in lower respiratory tract secretions in adults.. Eur. J. Clin. Microbiol. Infect. Dis. 8:299-300, 1989.
217. Sethi, S., Hill, S.L., Murphy, T.F. Serum antibodies to outer membrane proteins (OMPs) of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: Identification of OMP BI as an important antigen. Infect. Immun. 63:1516-1520, 1995.
218. Shurin, P.A., Marchant, C.D., Kim, C.H., Van Hare, G.F., Johnson, C.E., Tutihasi, M.A. and Knapp, L.J. Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. Pediatr. Infect. Dis. J. 2:34-38, 1983.
219. Simpson, I.N. and Plested, S.J. The origin and properties of β-lactamase satellite bands seen in isoelectric focusing. J. Antimicrob. Chemother. 12:127-131, 1983.
220. Singh, S., Cisera, K.M., Turnidge, J.D., and Russell, E.G. Selection of optimum laboratory tests for the identification of Moraxella catarrhalis. Pathology 29:206-208, 1997.
221. Slevin, N.J., Aitken, J. & Thornley, P.E. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections. Lancet 1:782-783, 1984.
222. Stackebrandt, E., Murray, G.E. and Trüper, H.G. Proteobacteria classis nov., a name for the phylogenetic taxon that includes the "purple bacteria and their relatives". Int. J. Syst. Bacteriol. 38:321-325, 1988.
223. Stobberingh, E.E., Davies, B.I. and van Boven, P.A. Branhamella catarrhalis: Antibiotic sensitivities and β-lactamases. J. Antimicrob. Chemother. 13:55-64, 1984.
224. Stobberingh, E.E., Wunderink, M., Philips, M. and Houben, A. Branhamella catarrhalis β-lactamase production and sensitivity to oral antibiotics, including new cephalosporins. J. Antimicrob. Chemother. 20:765-766, 1987.
225. Swedish Reference Group of Antibiotics. SRGA-M Methodology. Internet, Updated 01.02.1997.
226. Sweeny, K.G., Verghese, A. and Needham, C.A. In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains. Antimicrob. Ag. Chemother. 27:499-502, 1985.
227. Tager, I., and Speizer, F.E. Role of infection in chronic bronchitis. New Engl. J. Med. 292:563-571, 1975.
228. Thornley, P.E., Aitken, J., Drennan, C.J., MacVicar, J. & Slevin, N.J. Branhamella catarrhalis infection of the lower respiratory tract: Reliable diagnosis by sputum examination. Br. Med. J. 285:1537-1538, 1982.
229. Tjernberg I., Lindh E. and Ursing, J. A quantitative bacterial dot method for DNA-DNA hybridization and its correlation to the hydroxyapatite method. Curr. Microbiol. 18:77-81, 1989.
230. Tønjum, T., Bukholm, G., and Bøvre, K. Differentiation of some species of Neisseriaceae and other bacterial groups by DNA-DNA hybridization. APMIS 97:395-405, 1989.
231. Ursing, J. Hur klassificeras bakterier? Läkartidningen 83:709-715, 1986.
232. Vandamme, P., Pot, B., Gillis, M., De Vos, P., Kersters, K., and Swings, J. Polyphasic taxonomy, a consensus approach to bacterial systematics. Microbiol. Rev. 60:407-438, 1996.
233. Vaneechoutte, M.G., Verschraegen, G., Claeys, G. and Flamen, P. Rapid identification of Branhamella catarrhalis with 4-methylumbelliferyl butyrate. J. Clin. Microbiol. 26:1227-1228, 1988.
234. Vaneechoutte, M., Verschraegen, G., Claeys, G., Weise, B. and Van Den Abeele, A.M. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J. Clin. Microbiol. 28:2674-2680, 1990.
235. Vaneechoutte, M., Verschraegen, G., Claeys, G. and Van Den Abeele, A.M. Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens. J. Clin. Microbiol. 28:182-187, 1990.
236. Van Hare, G.F., Shurin, P.A., Marchant, C.D., Cartelli, N.A., Johnson, C.E., Fulton, D., Carlin, S., and Kim, C.H. Acute otitis media caused by Branhamella catarrhalis: Biology anf therapy. Rev. Infect. Dis. 9:16-27, 1987.
237. Verduin, C.M., Bootsma, H.S., Hol, J., Fleer, A., Jansze, M., Klingman, K.L., Murphy, T.F., and Van Dijk, H. Complement resistance in Moraxella (Branhamella) catarrhalis is mediated by high-molecular-weight outer membrane protein (HMW-OMP), abstr. B-137, p.189. In Abstracts of the 95th General Meeting of the American Society for Microbiology 1995. American Society for Microbiology, Washington, D.C., 1995.
238. Veron, M., Lenvoise-Furet, Coustere, Ged, C. and Grimont, F. Relatedness of three species of "False Neisseria", Neisseria caviae, Neisseria cuniculi, and Neisseria ovis, by DNA-DNA hybridizations and fatty acid analysis. Int. J. Syst. Bacteriol. 43:210-220, 1993.
239. von Graevenitz, A. Acinetobacter, Alcaligenes, Moraxella, and other nonfermentative Gram-negative bacteria. In: Murray, P.R. (ed. in chief). Manual of Clinical Microbilogy. Sixth Edition. ASM Press, Washington, D.C., 1995.
240. von Graevenitz, A. and Ratbone, R.R. Branhamella catarrhalis in respiratory secretions: Clinical correlation in 16 cases. Southern Med. J. 74:1095-1096, 1981.
241. Wallace Jr., R.J., Steingrube, V.A., Nash, D.R., Hollis, D.G., Flanagan, C., Brown, B.A., Labidi, A. and Weaver, R.E. BRO β-lactamases of Branhamella catarrhalis, and Moraxella subgenus Moraxella, including evidence for chromosomal β-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata. Antimicrob. Ag. Chemother. 33:1845-1854, 1989.
242. Waters, MJ., Steinfort, C.L. and Andrew, J.H. Branhamella catarrhalis, a respiratory tract pathogen. Aust. N. Z. J. Med. 15:579-584, 1985.
243. Weyant, R.S., Moss, C.W., Weaver, R.E., Hollis, D.G., Jordan, J.G., Cook, E.C., Daneshvar, M.I. Identification of unusual pathogenic Gram-negative aerobic and facultatively anaerobic bacteria. Second Edition, Williams & Wilkins, 1996.
244. Wilhelmus, K.R., Peacock, J., and Coster, D.J. Branhamella keratitis. Brit. J. Ophthalmol. 64:892-895, 1980.
245. Wong, V.K., and Mason, W.H. Branhamella catarrhalis as a cause of bacterial tracheitis. Pediatr. Infect. Dis. 6:945-946, 1987.
246. Wood, G.M., Johnson, B.C., and McCormack, J.G. Moraxella catarrhalis: Pathogenic significance in respiratory tract infections treated by community practitioners. Clin. Infect. Dis. 22:632-636, 1996.
247. Young, H. and Bain, S.S.R. Neisserial colonisation of the pharynx. Br. J. Vener. Dis. 59:228-231, 1983.
248. Yuen, K.Y., Seto, W.H. and Oug, S.G. The significance of Branhamella catarrhalis in bronchopulmonary infection a case control study. J. Infect. Dis. 19:251256, 1989.
249. Zheng, X. Beta-lactamase producing Branhamella in Beijing, China. Infect. Dis. J. 7:744, 1988.